凝血因子II,V,VII,IX,X和XI和死亡率 - 一个队列研究
Eng Soo Yap1,2, Willem M Lijfering1,3, Frits R Rosendaal1,4
1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Research and practice in thrombosis and haemostasis
|October 11, 2023
概括
高水平的凝血因子 (FII,FV,FVII,FIX,FX和FXI) 与静脉血栓症患者或一般人群中所有原因死亡风险的增加无关. 心脏病死亡与高的FX和FXI有很小的关联.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 流行病学 流行病学
背景情况:
- 升高的凝血因子 (FII,FV,FVII,FIX,FX,FXI) 与诸如中风和血栓形成等心血管事件有关.
- 关于这些因素与全因死亡率之间的关联的研究有限.
研究的目的:
- 调查凝血因子水平升高与全因死亡风险之间的关系.
- 评估这种关联在以前有静脉血栓症 (VT) 的患者和一般人群中.
主要方法:
- 一项队列研究涉及1919名先前接受过静脉治疗的患者和2800名匹配的社区对照.
- 测量了凝血因子水平,高水平被定义为高于90百分比.
- 考克斯回归分析根据年龄,性别和VT状态进行了调整.
主要成果:
- 没有发现FII,FV,FVII,FIX,FX和FXI水平升高与患者或对照群的全因死亡率之间有显著的关联.
- 在高的FX和FXI水平和心脏病死亡之间观察到一个小的关联,与之前的研究一致.
结论:
- 升高的凝血因子水平可能不会增加任何原因死亡的风险.
- 观察到与心脏病死亡的相关性需要进一步调查,特别是考虑到这个结果的样本规模很小.
相关概念视频
Coagulation
315
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
315
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
726
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
726
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
13
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
13
Extrinsic and Intrinsic Pathways of Hemostasis
8.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.1K
Introduction to Hemostasis
8.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.1K


